Search

everythinglearnresearchcommunity

for

Search:↓

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Careful management of blood thinners is crucial for lupus patients with APS.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document reviews key historical figures and discoveries in dermatology.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Finasteride helps hair growth by decreasing cell death in hair follicles.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New alopecia treatments aim for better results and fewer side effects.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Deleting Snai2 and Snai3 causes fatal autoimmunity.